Wegovy and Ozempic: could the new weight-loss drug also treat dementia?

By Tim Viney, Career Development Fellow, University of Oxford
Barbara Sarkany, DPhil Candidate, Alzheimer's, University of Oxford

Over 55 million people worldwide have dementia. This mind-robbing disease has a huge impact on society and the economy, so scientists are working hard to find ways to treat or prevent it. One of the avenues being explored is the new weight-loss jab, Wegovy.

Although age is by far the greatest risk factor for dementia, obesity and type 2 diabetes are also major risk factors for developing…

Read complete article

~	South Africa’s youth are a generation lost under democracy – study

~	Why reading and writing poems shouldn’t be considered a luxury in troubling times

~	A Hong Kong Facebook group on shop closure strives to survive allegations of inciting discontent

~	Vaping now more common than smoking among young people – and the risks go beyond lung and brain damage

~	Burkina Faso: Army Massacres 223 Villagers

~	Lebanon: Stepped-Up Repression of Syrians

~	Africa’s High Teenage Pregnancy Rate Demands Strong Response

~	Inflation is slowly falling while student debt is climbing: 6 graphs that explain the CPI

~	‘It bucked our lads up wonderfully’: the lightning-quick battle that marked the birth of the US-Australia military alliance

~	If plastic manufacturing goes up 10%, plastic pollution goes up 10% – and we’re set for a huge surge in production